doi: 10.1016/j.schres.2018.02.028.
Epub 2018 Feb 22.
Metabolic screening for patients with second-generation antipsychotic medication: A population-based study from 2004 to 2016
Affiliations
- PMID: 29477247
- DOI: 10.1016/j.schres.2018.02.028
Item in Clipboard
Metabolic screening for patients with second-generation antipsychotic medication: A population-based study from 2004 to 2016
Schizophr Res.
2018 Jul.
No abstract available
Keywords: Antipsychotics; Metabolic screening; Metabolic syndrome; Psychosis.
Similar articles
-
Second-generation antipsychotics and the metabolic syndrome.Curr Psychiatry Rep. 2005 Jun;7(3):153-4. doi: 10.1007/s11920-005-0044-1. Curr Psychiatry Rep. 2005. PMID: 15935125 No abstract available.
-
Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups.Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1387-1394. doi: 10.1002/pds.4244. Epub 2017 Jun 30. Pharmacoepidemiol Drug Saf. 2017. PMID: 28665012
-
Psychopharmacologic treatment of psychosis in children and adolescents: efficacy and management.Child Adolesc Psychiatr Clin N Am. 2013 Oct;22(4):727-44. doi: 10.1016/j.chc.2013.06.002. Child Adolesc Psychiatr Clin N Am. 2013. PMID: 24012083 Review.
-
The medical care of people with psychosis.Med J Aust. 2009 Feb 16;190(4):171-2. doi: 10.5694/j.1326-5377.2009.tb02339.x. Med J Aust. 2009. PMID: 19220177 No abstract available.
-
Metabolic risks in older adults receiving second-generation antipsychotic medication.Curr Psychiatry Rep. 2009 Feb;11(1):33-40. doi: 10.1007/s11920-009-0006-0. Curr Psychiatry Rep. 2009. PMID: 19187706 Review.
Cited by
-
Risk factors for metabolic syndrome in individuals with recent-onset psychosis at disease onset and after 1-year follow-up.Sci Rep. 2022 Jul 6;12(1):11386. doi: 10.1038/s41598-022-15479-x. Sci Rep. 2022. PMID: 35794221 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
